ModelEdge

Progenics Pharmaceuticals Inc
0000835887
Filing Type8-K
Filing Date6/21/2020
Updated6/22/20, 1:55 AM

Filing

8-K
Earnings Release

Exhibits

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
EX-3.1EX-3.1
EX-3.2EX-3.2
EX-99.1Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
GRAPHICGraphic
GRAPHICGraphic